Solutions / Products more
News / News more
Fapon takes the lead in introducing the COVID-19 Antigen Test Solution to satisfy the diversified needs of the market with high-quality raw materials and quality controls. The antigen test looks for viral protein fragments as a marker to identify the presence of infection, providing onsite results in minutes.Product Information Raw MaterialsRecommended PairsCatalog No.SourceCloneIsotypeApplicationPair 1FPZ0549Mouse5E4IgG1Coating FPZ0546Mouse5E7IgG1ConjugatePair 2FPZ0548Mouse5F9IgG1Coating FPZ0548Mouse5E7IgG1ConjugatePair 3FPZ0554Goat----Coating FPZ0546Mouse5E7IgG1ConjugatePair 4FPZ0573Mouse8A8...
Date: 2020 - 07 - 01
The rapid launch of Fapon COVID-19 S & N Recombinant Proteins for Immunoassay in February has been received positive feedback from customers with the demonstration of excellent performance in applications.  To continuously expand the COVID-19 product line, Fapon is officially launching the Anti-SARS-CoV-2 Fully Human RBD IgG Quality Control. Another product, the Anti-SARS-CoV-2 Fully Human RBD IgM Quality Control, will be introduced soon to join the collection.Fapon Anti-SARS-CoV-2 Fully Human RBD IgG Quality ControlFapon Anti-SARS-CoV-2 Fully Human RBD IgG Recombi...
Date: 2020 - 06 - 12
To address the unmet medical needs during this COVID-19 pandemic, Fapon once again manifests the strength of R&D capabilities to the world by being one of the leading biotechnology companies to launch the COVID-19 Naturalizing Antibodies Titer Testing Solution for ELISA and CLIA. This solution provides raw materials and quality controls to aid the evaluation of vaccine efficacy, antibody-drug effectiveness, convalescent plasma therapy, and seroepidemiological investigation. What is COVID-19 Neutralizing Antibodies  Neutralizing antibodies (NAbs) have significant preventive a...
Date: 2020 - 06 - 08
The world welcomes World Malaria Day on 25th April while the entire healthcare communities are grappling with the COVID-19 crisis, reminding other health issues troubling humankind should not be neglected.Malaria ranks No.3 killer in the world, claiming a child’s life every two minutes. Africa is the most malaria-infected area, which accounted for 93% of cases and 94% of deaths in the world based onRef:http://www.gbchealth.org/covid-19-and-malaria/http://www.rfi.fr/en/africa/20200411-covid-19-will-make-malaria-tracing-and-treatment-much-harder-whohttps://blogs.biomedcentral.com/bugbitten/2020/...
Date: 2020 - 04 - 24
To date, there are more than 200 countries around the world fighting the COVID-19 pandemic. Although the stages of virus transmission vary between countries, early disease diagnostics and screening are equally crucial to each area because it leads significantly to limit the spread of the virus.
Date: 2020 - 04 - 01
(Dongguan, China, March 30, 2020) -- Fapon Biotech Inc. (Fapon), a global leading IVD raw materials and one-stop solutions company offering products and technologies to enable the rapid development and production of reagents, initiated a global donation to give a total of 3 million PCR test components to IVD partners. Most PCR reagent manufacturers in China are currently using Fapon products for COVID-19 test development and production. Driven by the corporate mission 'Improving Human Health and Human Development', the company is dedicated to helping more overseas partners....
Date: 2020 - 03 - 30
On 28th February, the World Health Organization (WHO) escalated the COVID-19 risk assessment from 'high' to 'very high' as infected cases continue to increase significantly around the world, particularly in Asia, Europe and the Middle East.   As a leading IVD organization in China, Fapon took the lead to donate 2 million tests of high-quality one-step RT-PCR mix for the domestic development and production of COVID-19 PCR test kit and thereby ensuring a stable and sufficient supply in CDC, Hospitals, ICLs, etc.  In continuing to pursue the corporate mission——Improve Human Health ...
Date: 2020 - 03 - 09
(Dongguan, China, 5 March 2020) Fapon Biotech Inc. (Fapon) is premiering at booth 1F83, Medical Fair India from 5 to 7 March at the Bombay Convention and Exhibition Centre in Mumbai, India. Due to the traveling restriction caused by the COVID-19 virus, Fapon is one of the few Chinese exhibitors who attends the expo successfully.Although it’s the first exhibition Fapon holds in India, but actually, the company has more than 10 years of cooperation experience with the diagnostic companies in India. Alongside the attention drawn to the global health emergency of COVID-19, which the infected cases...
Date: 2020 - 03 - 05
The COVID-19 pneumonia is officially confirmed peaked by the World Health Organization (WHO) last week. WHO recognized the efforts China made in the fight. Local cases are also reporting a steep decline recently. Efforts across the nation welcome the preliminary success in the COVID-19 battle.
Date: 2020 - 03 - 03
It has been over twenty days as the novel coronavirus-infected pneumonia hits China and dampens Chinese New Year celebrations to home isolation. And in efforts to contain the virus outbreak, the Chinese government announced nationwide holiday extension to 10th February, with some provinces and cities are delaying the resumption of work and the school even longer. It is, undoubtedly, the virus outbreak is not only a global health emergency, but also a business challenge due to the suspended business operations.
Date: 2020 - 02 - 19